ILD is a rare but serious complication of EGFR-TKI because one-third of the patients with EGFR-TKI-associated lung injury die, even after receiving intensive supportive care, including supplemental oxygen, empirical antibiotics, systemic corticosteroids, and mechanical ventilation. This evidence concerns the gene EGFR and interstitial lung disease.